Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Financial Analyst Maintains Hold Rating for JDcom with Raised Price Target

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Finance_Assets (3)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On March 11, 2024, financial analyst Rob Sanderson from Loop Capital decided to maintain a Hold rating for JD.com but raised the price target to $26. Despite this change, the overall consensus among analysts for JD.com remains a Moderate Buy, with an average price target of $36.88, indicating a potential increase of 41.03% from the current price. It is worth noting that Loop Capital had previously adjusted JD.com’s price target to $39 from $42 while still keeping a Hold rating in place.

JD Stock Shows Strong Performance with 6.08% Increase in Share Price on March 11, 2024

On March 11, 2024, JD stock showed some positive momentum as it saw a significant increase in its share price. The price of JD shares increased by $1.50 since the market last closed, representing a 6.08% increase. The stock opened at $25.60, which was $0.85 higher than its previous close. This opening price indicated a strong start for JD on that day, setting the stage for a positive trading session. Investors and analysts may have been encouraged by this price momentum and the positive movement seen in JD stock on March 11. The increase in share price could be attributed to a variety of factors, including market conditions, company performance, or investor sentiment. Overall, the performance of JD stock on March 11, 2024, demonstrated a positive trend with a notable increase in share price. Investors will continue to monitor the stock’s performance and market conditions to make informed decisions about their investment strategies.

JD Stock Performance Analysis: Revenue Holds Steady While Net Income and EPS Show Impressive Growth

On March 11, 2024, JD stock performance showed some interesting trends based on the latest financial data provided by CNN Money.

Total revenue for JD stood at $153.09 billion for the past year, with $42.34 billion in the fourth quarter. The total revenue has remained flat since last year and also since the last quarter. This indicates that JD has been able to maintain a consistent level of revenue over the past year.

Net income for JD was reported at $3.41 billion for the past year, with $468.83 million in the fourth quarter. The net income has increased by an impressive 121.28% since last year, showing that JD has been able to significantly improve its profitability. However, the net income has held flat since the last quarter.

Earnings per share (EPS) for JD were reported at $2.15 for the past year, with $0.30 in the fourth quarter. The EPS has increased by a substantial 121.98% since last year. However, the EPS has decreased by 57.13% since the last quarter.

Overall, the financial data for JD on March 11, 2024, shows a mixed performance with strong growth in net income and earnings per share over the past year, but some challenges in maintaining the same level of profitability in the most recent quarter. Investors will be closely watching JD’s future performance to see if the company can continue to grow its revenue and profitability.

Tags: JD
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Investor Sentiment and Options Trading Activity for Pfizer

Neurotechnology

Monolithic Power Systems MPWR A 15Year Success Story

Biotechnology Stock Market Today (1)

Anticipation Builds for BioXcel Therapeutics Earnings Report

Recommended

Emergent BioSolutions Stock

A Tale of Two Realities: Emergent BioSolutions’ Social Mission and Financial Strain

4 weeks ago
Food Retailers Stock Bull Market

JP Morgan Analyst Maintains Neutral Rating on Tyson Foods with Revised Price Target

2 years ago
MMM stock news

Bearish Sentiment Surrounds Air Lease NYSE AL Trading

2 years ago
QuantumScape Stock

QuantumScape Leadership Executes Major Stock Sales, Raising Investor Concerns

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

Leadership Crisis at Nestlé Sparks Investor Concerns

Standex Shares Plunge Amid Technical Warnings and Insider Selling

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

Trending

Pfizer Stock
Healthcare

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

by Dieter Jaworski
September 22, 2025
0

In a move signaling its serious intent to capture a share of the lucrative anti-obesity drug market,...

Nike Stock

Nike Shares Face Critical Earnings Test

September 22, 2025
Tutor Perini Stock

Insider Sales at Tutor Perini Coincide with Stock Peak

September 22, 2025
Ubiquiti Stock

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

September 22, 2025
BioNTech Stock

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena
  • Nike Shares Face Critical Earnings Test
  • Insider Sales at Tutor Perini Coincide with Stock Peak

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com